Shanghai Henlius Biotech refiles $500m IPO application
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Shanghai Henlius Biotech refiles $500m IPO application

Gina Lee
July 08, 2019 05:00 AM
Reckitthealthcare_fotolia_230x150

Shanghai Henlius Biotech has resubmitted its application to list on the Hong Kong Stock Exchange with an IPO worth around $500m.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquityChina Merchants Bank CoChinaChina International Capital CorpCitiHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificEmerging MarketsSRI
GL
Gina Lee
Gift this article